StockData
VRXANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as VRXAW

Veraxa Biotech AG - Post de-SPAC

Last filing: 20-F on Jun 16, 2026
$1.00−0.11 (-9.91%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Veraxa Biotech AG - Post de-SPAC revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Veraxa Biotech AG - Post de-SPAC does not break out revenue by segment, region or product in the tagged data of its filings for this period type.